Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain

Scritto il 07/02/2026
da Miquel Micó

No abstract

BMC Infect Dis. 2026 Feb 6. doi: 10.1186/s12879-026-12796-8. Online ahead of print.

NO ABSTRACT

PMID:41652586 | DOI:10.1186/s12879-026-12796-8